Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

[Menstrual migraine].

B de Lignières1

  • 1Service endocrinologie et médecine de la reproduction, hôpital Necker, Paris.

La Revue Du Praticien
|February 11, 1990
PubMed
Summary
This summary is machine-generated.

Menstrual migraine affects 10-20% of women due to cyclic estrogen drops. Cyclic percutaneous estradiol administration is the best preventive treatment, stabilizing estrogen levels to prevent attacks.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Combined hormone replacement therapy and risk of breast cancer in a French cohort study of 3175 women.

Climacteric : the journal of the International Menopause Society·2003
Same author

Effects of progestogens on the postmenopausal breast.

Climacteric : the journal of the International Menopause Society·2002
Same author

[Compliance with hormone replacement therapy in menopause: effect of an original education program. The COMET study].

Gynecologie, obstetrique & fertilite·2002
Same author

Endometrial hyperplasia. Risks, recognition and the search for a safe hormone replacement regimen.

The Journal of reproductive medicine·2001
Same author

Recommendations on the risk of ischaemic stroke associated with use of combined oral contraceptives and hormone replacement therapy in women with migraine. The International Headache Society Task Force on Combined Oral Contraceptives & Hormone Replacement Therapy.

Cephalalgia : an international journal of headache·2000
Same author

The place of combined oral contraceptives in contraception.

Cephalalgia : an international journal of headache·2000

Area of Science:

  • Neurology
  • Endocrinology
  • Gynecology

Context:

  • Cyclic estrogen fluctuations during menstruation trigger migraines in 10-20% of women.
  • Migraine attacks worsen or are triggered by menstruation in 60% of women with existing migraine.
  • Oral contraceptives can initiate menstrual migraine in women without prior history.

Purpose:

  • To investigate the role of estrogen levels in menstrual migraine.
  • To evaluate the efficacy of percutaneous estradiol administration for preventing menstrual migraine.

Summary:

  • Low estrogen levels during menstruation are a primary cause of common migraine.
  • High-dose progestogens and insufficient oral estrogens can exacerbate migraines.
  • Cyclic percutaneous estradiol administration effectively prevents menstrual migraine by stabilizing estrogen levels.

Related Experiment Videos

Impact:

  • Identifies estrogen fluctuations as a key factor in menstrual migraine.
  • Establishes cyclic percutaneous estradiol as the optimal preventive therapy.
  • Highlights the importance of maintaining stable estrogen levels for migraine management.